Drug intelligence / Profile preview

PHEC-66

Development stage
Preclinical
Lead developer
Argent BioPharma
Modality
Small Molecules
Administration
Topical
01

Overview

PHEC-66 is a standardized cannabis extract primarily being developed for the treatment of melanoma. It exerts its anti-tumor effects by inhibiting the viability of various melanoma cell lines, including MM418-C1, MM329, C32, and D24, through the induction of apoptosis and modulation of cell survival pathways. Research has demonstrated that PHEC-66 can have nuanced interactions with conventional chemotherapy; it shows potential additive effects when combined with auranofin or docetaxel, but may exhibit antagonistic effects when paired with cisplatin. The extract's mechanism of action is thought to involve the endocannabinoid system and the regulation of DNA damage responses and intracellular signaling. It is currently in the preclinical stages of development.

Other names
Cannabis extract PHEC-66
02

Targets

CNR2 (Cannabinoid receptor type 2)

Beyond the preview

Go deeper on PHEC-66.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHEC-66.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call